Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biostime
- Development stage
- Unknown
- Lead developer
- H&H Group
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Biostime is a brand of probiotic supplements specifically formulated for infants and children, developed by the Biostime Institute of Nutrition and Care (a division of H&H Group). The product typically consists of a combination of probiotic strains, including *Bifidobacterium infantis*, *Bifidobacterium bifidum*, and *Lactobacillus helveticus*, often supplemented with prebiotics like fructooligosaccharides (FOS). It is intended to support the development of a healthy gut microbiome, improve digestibility, and enhance immune function in formula-fed or breast-fed infants. Clinical research, such as the study NCT01632241, has investigated its efficacy in modulating gastrointestinal flora and supporting systemic immunity in healthy infants.
- Brand names
- Biostime
- Other names
- Biostime ProbioticsBiostime Probiotics for Infants
Beyond the preview
Go deeper on Biostime.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biostime.